Skip to content

Altheia Science vs Cantargia AB

Altheia Science logo

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative tools. Founded by renowned Italian scientists

6 employees · est. 2017 · Milano, Italy

VS
Cantargia AB logo

Cantargia AB

A Swedish listed biotechnology company

32 employees · est. 2010 · Lund, Sweden

Cantargia AB is the older company (2017 vs 2010); Cantargia AB is the larger of the two.

Side-by-Side Comparison

Altheia Science Cantargia AB
Founded
2017 2010 older
Headquarters
Milano, Italy Lund, Sweden
Employees
6 32 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Medical Devices
Funding Stage
Series A Post-IPO Equity
Total Funding
$11.00M $257.00M
Funding Rounds
1 2
Taxonomy
Gene TherapyAutoimmunityAutoimmune DiseasesCancerCell TherapyGene Editing +8 Antibody-based TherapiesClinical ProgramsIL1RAPCancer TreatmentAutoimmune DiseasesInflammatory Diseases +8
Website
altheiascience.com cantargia.com
Altheia Science logo

About Altheia Science

Altheia Science is a cutting-edge biotechnology startup headquartered in Italy, founded in 2017 by renowned Italian scientists Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD along with AurorA-TT. The company specializes in developing innovative treatments for autoimmune diseases and can...

Cantargia AB logo

About Cantargia AB

Cantargia is a Swedish listed biotechnology company that focuses on developing antibody-based therapies targeting IL1RAP. The company's clinical programs include nadunolimab, which is currently in phase II development for the treatment of cancer, and CAN10 in phase I development for autoimmune/infla...

Also comparing in this category

Comparing more than these two?

Get Altheia Science, Cantargia AB and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Altheia Science compare?

A PDF of Altheia Science and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Altheia Science was founded in 2017, based in Milano, Italy, with 6 employees. Altheia Science is a cutting-edge biotechnology startup headquartered in Italy, founded in 2017 by renowned Italian scientists Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD along with Au. Cantargia AB was founded in 2010, based in Lund, Sweden, with 32 employees. Cantargia is a Swedish listed biotechnology company that focuses on developing antibody-based therapies targeting IL1RAP. The company's clinical programs include nadunolimab, which is currently in pha.
Altheia Science has raised $11.00M and Cantargia AB $257.00M. Latest stage: Altheia Science Series A, Cantargia AB Post-IPO Equity.
Both work in Biotechnology and Health and Wellness and list autoimmune diseases and hematopoietic stem cells among their focus areas.

Compare Altheia Science with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Altheia Science on 11 Sep 2024, and Cantargia AB on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout